Regulation of hypothalamic proopiomelanocortin by leptin in lean and obese rats

Neuroendocrinology

Volumn 70, Issue 6, 1999, Pages 377-383

  Korner, Judith ^a   Chua Jr , Streamson C ^a   Williams, Julie A ^b   Leibel, Rudolph L ^a   Wardlaw, Sharon L ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b VASSAR COLLEGE   (United States)

Author keywords

Leptin; Melanocortin stimulating hormone; Obesity; Proopiomelanocortin

Indexed keywords

HETEROGENEOUS NUCLEAR RNA; LEPTIN; LEPTIN RECEPTOR; MESSENGER RNA; PROOPIOMELANOCORTIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CELL LEVEL; CONTROLLED STUDY; CYTOPLASM; FOOD INTAKE; GENETIC TRANSCRIPTION; HOMEOSTASIS; HYPOTHALAMUS; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

EID: 0033405582     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054499     Document Type: Article

References (45)

1. Zhang Y. Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
2. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS: Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1998;1:445-450.
3. Smith Al, Funder JW: Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 1988; 9:159-179.
4. Kim EM, Welch CC, Grace MK, Billington CJ, Levine AS: Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in arcuate nucleus. Am J Physiol 1996;270:R1019-R1024.
5. Brady LS, Smith MA, Gold PW, Herkenham M: Altered expression of hypothalamic neuro-peptide mRNAs in food-restriction and food-deprived rats. Neuroendocrinology 1990;52: 441-447.
6. Bergendahl M, Wiemann JN, Clifton DK, Huhtaniemi I, Steiner RA: Short-term starvation decreases POMC mRNA but does not alter GnRH mRNA in the brain of adult male rats. Neuroendocrinology 1992;56:913-920.
7. Fan W, Boston BA, Kesterson RA, Hruby VJ, Cone RD: Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997;185:165-168.
8. Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P. Seeley RJ: Central infusion of melanocortin agonist MTII in rats: Assessment c-Fos expression and taste aversion. Am J Physiol 1998;274:R248-R254.
9. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, Schwartz MW: Melanocortin receptors in leptin effects. Nature 1997;390:349.
10. Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, Nakao K: Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 1998;249:107-110.
11. Comuzzie AG, Hixon JE, Almasy L, Mitchell BD, Mahaney M, Dyer TD, Stern MP, Mac-Cluer JW, Blangero J: A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997;15:273-276.
12. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Grüters A: Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1948;19:155-157.
13. Jackson RS, Creemers JWM, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, Hutton JC, O'Rahilly S: Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997;16:303-306.
14. Leibel RL, Chung WK, Chua SC Jr: The molecular genetics of rodent single gene obesities. J Biol Chem 1997;272:31937-31940.
15. Lu D, Willard Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkinson WO, Cone RD: Agouti protein is an antagonist of the melanocyte-stimulating hormone receptor. Nature 1994;371:799-802.
16. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-141.
17. Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y. Gantz I, Barsh GS: Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997; 278:135-138.
18. Shutter JR, Graham M, Kinsey AC, Scully S, Lüthy R, Stark KL: Hypothalamic expression of ART. a novel gene related to agouti, is upregulated in obese and diabetic mutant mice. Genes Dev 1997;11:593-602.
19. Fong TM, Mao C, MacNeil T, Kalyani R, Smith T, Weinberg D, Tota MR, Van der Ploeg LHT: ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem Biophys Res Commun 1997;237:629-631.
20. Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL: Overexpression of agrt leads to obesity in transgenic mice. Nat Genet 1997;17 273-274.
21. Thornton JF, Cheung CC, Clifton DK, Steiner RA: Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. Endocrinology 1997;138:5063-5066.
22. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG: Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997;46:2119-2123.
23. Mizuno TM, Kleopoulos SP, Bergen HT, Roberts JL, Priest CA, Mobbs CV: Hypothalamic pro-opiomelanocortin mRNA is reduced by fasting in ob/ob and db/db mice, but is stimulated by leptin. Diabetes 1988;47:294-297.
24. Cheung CC, Clifton DK, Steiner RA: Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. Endocrinology 1997;138:4489-4492.
25. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B: Leptin receptor immunoreactivity in chemically defined targed neurons of the hypothalamus. J Neurosci 1998;18:559-572.
26. Koletsky S: Obese spontaneous hypertensive rats: A model for the study of atherosclerosis. Exp Mol Pathol 1973;19:53-60.
27. Takaya K, Ogawa Y, Hiraoka J, Hosoda K, Yamori Y, Nakao K, Koletsky RJ: Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet 1996;14:130-131.
28. Wu-Peng XS, Chua SC Jr, Okada N, Liu SM, Nicolson M, Leibel RL: Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr). Diabetes 1997;46:513-518.
29. Hayden JF, Johnson LR, Maickel RP: Construction and implantation of a permanent cannula for making injections into the lateral ventricle of the rat brain. Life Sci 1966;5:1509-1515.
30. Wardlaw SL, Smeal MM, Markowitz CE: Antagonism of β-endorphin-induced prolactin release by α-melanocyte-stimulating hormone and corticotropin-like intermediate lobe peptide. Endocrinology 1986;119:112-118.
31. Wardlaw SL, McCarthy KC, Conwell IM: Glucocorticoid regulation of hypothalamic proopiomelanocortin. Neuroendocrinology 1998; 67:51-57.
32. Bradford M: A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248.
33. Autelitano DJ, Blum M, Lopingco M, Allen RG, Roberts JL: Corticotropin-releasing factor differentially regulates anterior and intermediate pituitary lobe proopiomelanocortin gene transcription, nuclear precursor RNA and mature mRNA in vivo. Neuroendocrinology 1990;51:123-130.
34. Blum M, Roberts JL, Wardlaw SL: Androgen regulation of proopiomelanocortin gene expression and peptide content in the basal hypothalamus. Endocrinology 1989;124:2283-2288.
35. Scarbrough K, Jakubowski M, Levin N, Wise PM, Roberts JL: The effect of time of day on levels of hypothalamic proopiomelanocortin primary transcript, processing intermediate and messenger ribonucleic acid in proestrous and estrous rats. Endocrinology 1994;134:555-565.
36. Wardlaw SL: Regulation of β-endorphin, corticotropin-like intermediate lobe peptide, and α-melanotropin-stimulating hormone in the hypothalamus by testosterone. Endocrinology 1986;119:19-24.
37. Meador-Woodruff JH, Pellerito B, Bronstein D, Lin HL, Ling N, Akil H: Differential effects of haloperidol on the rat pituitary: Decreased biosynthesis, processing and release of anterior lobe pro-opiomelanocortin. Neuroendocrinology 1990;51:294-303.
38. Sahu A: Evidence suggesting that galanin (GAL). melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. Endocrinology 1998;139:795-798.
39. Beaulieu S, Gagne B, Barden N: Glucocorticoid regulation of proopiomelanocortin messenger ribonucleic acid content of rat hypothalamus. Mol Endocrinol 1988;2:727-731.
40. Long Y, Couet J, Simard J, Pelletier G: Glucocorticoid regulation of proopiomelanocortin mRNA levels in rat arcuate nucleus. Mol Cel Neurosci 1990;1:78-83.
41. Chowen-Breed J, Fraser HML Vician L, Damassa DAL Clifton DKL Steiner RA: Testosterone regulation of proopiomelanocortin messenger ribonucleic acid in the arcuate nucleus of the male rat. Endocrinology 1989;124:1697-1702.
42. Jégou S, Tranchand-Bunel D, Delbende C, Blasquez C. Vaudry H: Characterization of α-MSH-related peptides released from rat hypothalamic neurons in vitro. Mol Brain Res 1989; 5:219-226.
43. Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD: Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994;8:1298-1308.
44. Williams G, Shellard L, Lewis DE, McKibbin PE, McCarthy HD, Koeslag DG, Russell JC: Hypothalamic neuropeptide Y disturbances in the obese (cp/cp) JCR:LA corpulent rat. Peptides 1992;13:537-540.
45. O'Donohue TL, Handelmann GE, Miller RL, Jacobowitz DM: A-Acetylation regulates the behavioral activity of α-melanotropin in a multineurotransmitter neuron. Science 1982;215: 1125-1127.